USPTO serial 88800804
V-OVS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 28, 2023
- Examiner
- GILBERT, REBECCA L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with V-OVS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Vetter Pharma-Fertigung GmbH & Co. KG
Ravensburg, DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
Ravensburg, DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
Ravensburg, DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin ALPRIN LAW OFFICES, P.C.5 PINEHURST CIRCLE, N.W.WASHINGTON, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and medicines, namely, orally administrable solutions, injectable solutions, solids and semisolids capable of being dissolved in liquids and solvents, powders in ready-to-use form or capable of reconstitution, all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, oral and laryngeal disease, optical and cranial disorders; eyedrops; solutions for contact lenses; pharmaceutical preparations for use in the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, oral and laryngeal disease, optical and cranial disorders, sold in prefilled syringes; syringe components of syringes sold prefilled with pharmaceutical preparations for use in the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, oral and laryngeal disease, optical and cranial disorders, and alcohol, iodine, sterilizing agents and cleaning solutions for medical purposes; premoistened cotton swabs for medical purposes; adhesive bandages; surgical bandages; bandages for skin wounds | ACTIVE | — |
| 010 | Medical injection devices, namely, injection syringes, pen-type injectors, autoinjectors, disposable and reusable syringes, syringe holder attachments to aid in holding injection needles perpendicular to the skin, double or multi-chamber syringes and injector pens; accessories for medical injection devices and medical containers, namely, syringes, syringe closures and partial syringe closures; disposable cannulas, blood collection vials for medical use; elastic bandages, bandages for anatomical joints, orthopedic support bandages and compression bandages | ACTIVE | — |
| 039 | Aseptic, sterile bottling of substances, namely, pharmaceutical, chemical and biological preparations and medicines | ACTIVE | — |
| 042 | Microbiological laboratory testing and analysis, chemical laboratory research, all services for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 039
- Other trademarks in Class 042
- Similar marks named V-OVS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 28, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 28, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 10, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 10, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 21, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2022 | RPUB | NOA CANCELLED; REPUBLICATION REQUIRED | — |
| Dec 2, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Dec 1, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 1, 2022 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Nov 29, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Nov 16, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 14, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 14, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 14, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 14, 2022 | TPAD | TEAS PETITION TO AMEND BASIS RECEIVED | — |
| May 19, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 17, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 17, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 17, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 12, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 10, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 10, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 10, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 18, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 17, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 17, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 17, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 17, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 17, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 12, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 12, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 12, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2021 | ALIE | ASSIGNED TO LIE | — |
| Nov 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 22, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 21, 2020 | NWAP | NEW APPLICATION ENTERED | — |